Vaccine production platform using monoclonal suspended MDCK cells adapted to chemically defined culture media.
Features of the suspended MDCK cell platform: ■ Monoclonal suspended MDCK cells Cells adapted to animal component-free serum-free medium without the use of genetic recombination from ATCC MDCK (NBL-2) CCL-34. ■ 4Cell MDXK CD Medium A chemically defined medium designed for the growth and infection of MDCK cells, free from animal-derived components and proteins. ■ Support Services We provide technical support throughout cell bank testing, safety testing, characterization, upstream and downstream processes, and scale-up.
Inquire About This Product
Related Videos
basic information
Our floating MDCK cell platform is a comprehensive and scalable solution designed specifically for developers and manufacturers of vaccines targeting influenza.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（4）
Download All Catalogs
Company information
Sartorius Stedim, established in 2007 through the merger of the German company Sartorius, founded in 1870, and the French company Stedim, is a pioneer in "Single-Use Technology (SUT)." As a company capable of providing comprehensive technical support to the pharmaceutical and biotechnology industries, its cutting-edge technology is highly regarded worldwide in the fields of scientific instruments and biotechnology.